GALMED PHARMACEUTICALS LTD (GLMD) Stock Balance Sheet
USA - NASDAQ:GLMD - IL0011313900 - Common Stock
1.37 USD
+0.03 (+2.24%)
1.35 USD
-0.02 (-1.46%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.96M | 4.65M | 2.86M | 2.02M | 2.88M | |||
| Marketable Securities | 15.56M | 10.68M | 9.78M | 11.77M | 31.93M | |||
| Receivables | 433.00K | 209.00K | 165.00K | 120.00K | 80.00K | |||
| Other Current Assets | 123.00K | 584.00K | 432.00K | 810.00K | 1.16M | |||
| Total Current Assets | 21.08M | 16.12M | 13.24M | 14.72M | 36.05M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 0.00 | 125.00K | 340.00K | 550.00K | |||
| Investments And Advances | 1.59M | 2.12M | 3.27M | 1.50M | N/A | |||
| Other Non-Current Assets | 267.00K | 257.00K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.86M | 2.38M | 3.39M | 1.84M | 560.00K | |||
| TOTAL ASSETS | 22.94M | 18.50M | 16.63M | 16.56M | 36.61M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | N/A | N/A | N/A | N/A | N/A | |||
| Accounts Payable | 1.37M | 1.31M | 1.88M | 2.56M | 4.87M | |||
| Other Current Liabilities | 1.05M | 865.00K | 871.00K | 530.00K | 1.01M | |||
| Total Current Liabilities | 2.42M | 2.17M | 2.75M | 3.09M | 5.88M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 40.00K | 230.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 50.00K | 230.00K | |||
| TOTAL LIABILITIES | 2.42M | 2.17M | 2.75M | 3.14M | 6.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -204.07M | -200.47M | -192.95M | -186.04M | -168.17M | |||
| Additional Paid In Capital | 222.30M | 216.47M | 207.08M | 200.14M | 198.77M | |||
| Common Shares | 2.69M | 742.00K | 209.00K | 70.00K | 70.00K | |||
| Shares Outstanding | 5.30M | 1.66M | 420.40K | 1.68M | 1.67M | |||
| Tangible Book Value per Share | 3.87 | 9.81 | 33.01 | 7.99 | 18.26 | |||
| Total Shareholders' Equity | 20.52M | 16.33M | 13.88M | 13.42M | 30.50M | |||
| TOTAL LIABILITIES AND EQUITY | 22.94M | 18.50M | 16.63M | 16.56M | 36.61M | |||
| Statistics | ||||||||
| Current Ratio | 8.71 | 7.42 | 4.81 | 4.76 | 6.13 | |||
| Return On Assets (ROA) | -38.01% | -40.65% | -41.55% | -107.91% | -88.69% | |||
| Return On Equity (ROE) | -42.50% | -46.06% | -49.79% | -133.16% | -106.46% | |||
All data in USD , ROIC based on taxRate of 0.21